| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.36e-06 | 5 | 104 | 3 | GO:0030156 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 1.28e-07 | 48 | 103 | 6 | GO:0032391 | |
| GeneOntologyCellularComponent | ciliary transition zone | 2.97e-06 | 81 | 103 | 6 | GO:0035869 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 6.53e-05 | 139 | 103 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.11e-04 | 153 | 103 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | WHRN ERBB2 SYNE1 CYFIP2 RAD50 GDPD5 RHPN2 OSBPL6 PLEC ALOX12B MYO16 HCRT PKN3 SORL1 | 1.95e-04 | 934 | 103 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | photoreceptor outer segment | 2.23e-04 | 111 | 103 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | FHF complex | 2.38e-04 | 5 | 103 | 2 | GO:0070695 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 2.78e-04 | 26 | 103 | 3 | GO:0097381 | |
| GeneOntologyCellularComponent | manchette | 3.48e-04 | 28 | 103 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | non-motile cilium | 4.23e-04 | 196 | 103 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | actin cytoskeleton | WHRN SIPA1L3 CDC42BPB MPRIP SPTBN5 TFPT MACF1 MYO16 FCHSD1 CCDC102A | 5.54e-04 | 576 | 103 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | symbiont cell surface | 6.60e-04 | 8 | 103 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | cis-Golgi network | 8.29e-04 | 85 | 103 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | other organism part | 8.46e-04 | 9 | 103 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | bBAF complex | 1.05e-03 | 10 | 103 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.21e-03 | 161 | 103 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | centriole | 1.63e-03 | 172 | 103 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-plasma membrane contact site | 1.81e-03 | 13 | 103 | 2 | GO:0140268 | |
| GeneOntologyCellularComponent | microtubule organizing center | WHRN PLA2G3 CEP290 HAUS5 SFI1 HOOK3 CEP295 HOOK2 CCDC65 UVRAG KIFC1 PCNT | 1.88e-03 | 919 | 103 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | npBAF complex | 2.11e-03 | 14 | 103 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 2.11e-03 | 14 | 103 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | mitotic spindle microtubule | 2.11e-03 | 14 | 103 | 2 | GO:1990498 | |
| GeneOntologyCellularComponent | HOPS complex | 2.11e-03 | 14 | 103 | 2 | GO:0030897 | |
| GeneOntologyCellularComponent | nBAF complex | 2.76e-03 | 16 | 103 | 2 | GO:0071565 | |
| Domain | Actinin_actin-bd_CS | 1.18e-07 | 23 | 99 | 5 | IPR001589 | |
| Domain | ACTININ_2 | 1.18e-07 | 23 | 99 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.18e-07 | 23 | 99 | 5 | PS00019 | |
| Domain | Spectrin_repeat | 4.06e-07 | 29 | 99 | 5 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 6.79e-07 | 32 | 99 | 5 | IPR018159 | |
| Domain | SPEC | 6.79e-07 | 32 | 99 | 5 | SM00150 | |
| Domain | Spectrin | 6.09e-06 | 23 | 99 | 4 | PF00435 | |
| Domain | CH | 2.43e-05 | 65 | 99 | 5 | SM00033 | |
| Domain | SnAC | 2.78e-05 | 2 | 99 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 2.78e-05 | 2 | 99 | 2 | IPR014978 | |
| Domain | SnAC | 2.78e-05 | 2 | 99 | 2 | IPR029295 | |
| Domain | SnAC | 2.78e-05 | 2 | 99 | 2 | PF14619 | |
| Domain | QLQ | 2.78e-05 | 2 | 99 | 2 | SM00951 | |
| Domain | QLQ | 2.78e-05 | 2 | 99 | 2 | PS51666 | |
| Domain | QLQ | 2.78e-05 | 2 | 99 | 2 | PF08880 | |
| Domain | CH | 3.48e-05 | 70 | 99 | 5 | PF00307 | |
| Domain | - | 3.73e-05 | 71 | 99 | 5 | 1.10.418.10 | |
| Domain | CH | 4.27e-05 | 73 | 99 | 5 | PS50021 | |
| Domain | BROMODOMAIN_1 | 4.29e-05 | 37 | 99 | 4 | PS00633 | |
| Domain | Bromodomain | 4.77e-05 | 38 | 99 | 4 | PF00439 | |
| Domain | CH-domain | 4.86e-05 | 75 | 99 | 5 | IPR001715 | |
| Domain | BROMODOMAIN_2 | 6.47e-05 | 41 | 99 | 4 | PS50014 | |
| Domain | BROMO | 7.12e-05 | 42 | 99 | 4 | SM00297 | |
| Domain | Bromodomain | 7.12e-05 | 42 | 99 | 4 | IPR001487 | |
| Domain | - | 7.12e-05 | 42 | 99 | 4 | 1.20.920.10 | |
| Domain | SPAR_C | 8.32e-05 | 3 | 99 | 2 | PF11881 | |
| Domain | SIPA1L_C | 8.32e-05 | 3 | 99 | 2 | IPR021818 | |
| Domain | SH3_2 | 9.37e-05 | 86 | 99 | 5 | IPR011511 | |
| Domain | SH3_2 | 9.37e-05 | 86 | 99 | 5 | PF07653 | |
| Domain | HSA | 1.66e-04 | 4 | 99 | 2 | SM00573 | |
| Domain | HSA | 1.66e-04 | 4 | 99 | 2 | PS51204 | |
| Domain | HSA_dom | 1.66e-04 | 4 | 99 | 2 | IPR014012 | |
| Domain | HSA | 1.66e-04 | 4 | 99 | 2 | PF07529 | |
| Domain | Anaphylatoxin_comp_syst | 2.75e-04 | 5 | 99 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.75e-04 | 5 | 99 | 2 | IPR001840 | |
| Domain | Bromodomain_CS | 3.44e-04 | 26 | 99 | 3 | IPR018359 | |
| Domain | BRK | 4.11e-04 | 6 | 99 | 2 | SM00592 | |
| Domain | - | 4.11e-04 | 6 | 99 | 2 | 3.90.1290.10 | |
| Domain | HOOK | 4.11e-04 | 6 | 99 | 2 | PF05622 | |
| Domain | Hook-related_fam | 4.11e-04 | 6 | 99 | 2 | IPR008636 | |
| Domain | BRK_domain | 4.11e-04 | 6 | 99 | 2 | IPR006576 | |
| Domain | BRK | 4.11e-04 | 6 | 99 | 2 | PF07533 | |
| Domain | ANATO | 5.74e-04 | 7 | 99 | 2 | SM00104 | |
| Domain | Plectin_repeat | 5.74e-04 | 7 | 99 | 2 | IPR001101 | |
| Domain | ANATO | 5.74e-04 | 7 | 99 | 2 | PF01821 | |
| Domain | Hr1 | 5.74e-04 | 7 | 99 | 2 | SM00742 | |
| Domain | Plectin | 5.74e-04 | 7 | 99 | 2 | PF00681 | |
| Domain | ANAPHYLATOXIN_2 | 5.74e-04 | 7 | 99 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 5.74e-04 | 7 | 99 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 5.74e-04 | 7 | 99 | 2 | IPR000020 | |
| Domain | PLEC | 5.74e-04 | 7 | 99 | 2 | SM00250 | |
| Domain | FN3 | 6.68e-04 | 199 | 99 | 6 | PS50853 | |
| Domain | Thiol-ester_cl | 7.63e-04 | 8 | 99 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 7.63e-04 | 8 | 99 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 7.63e-04 | 8 | 99 | 2 | IPR019742 | |
| Domain | HR1 | 7.63e-04 | 8 | 99 | 2 | PF02185 | |
| Domain | SH3_9 | 7.85e-04 | 78 | 99 | 4 | PF14604 | |
| Domain | FN3_dom | 8.63e-04 | 209 | 99 | 6 | IPR003961 | |
| Domain | SH3 | 1.02e-03 | 216 | 99 | 6 | PS50002 | |
| Domain | SH3_domain | 1.12e-03 | 220 | 99 | 6 | IPR001452 | |
| Domain | A2M_N | 1.22e-03 | 10 | 99 | 2 | PF01835 | |
| Domain | A2M_N | 1.22e-03 | 10 | 99 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.22e-03 | 10 | 99 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.22e-03 | 10 | 99 | 2 | PS00477 | |
| Domain | A2M | 1.22e-03 | 10 | 99 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.22e-03 | 10 | 99 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.22e-03 | 10 | 99 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.22e-03 | 10 | 99 | 2 | PF07703 | |
| Domain | Rap_GAP | 1.22e-03 | 10 | 99 | 2 | PF02145 | |
| Domain | A2M_recep | 1.22e-03 | 10 | 99 | 2 | PF07677 | |
| Domain | A2M_comp | 1.22e-03 | 10 | 99 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.22e-03 | 10 | 99 | 2 | IPR001599 | |
| Domain | Rap_GAP_dom | 1.48e-03 | 11 | 99 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.48e-03 | 11 | 99 | 2 | PS50085 | |
| Domain | L_dom-like | 1.81e-03 | 328 | 99 | 7 | IPR032675 | |
| Domain | SSD | 2.09e-03 | 13 | 99 | 2 | IPR000731 | |
| Domain | SSD | 2.09e-03 | 13 | 99 | 2 | PS50156 | |
| Domain | LRR_8 | 2.17e-03 | 171 | 99 | 5 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.52e-03 | 177 | 99 | 5 | IPR003591 | |
| Domain | LRR_TYP | 2.52e-03 | 177 | 99 | 5 | SM00369 | |
| Domain | FN3 | 3.05e-03 | 185 | 99 | 5 | SM00060 | |
| Domain | Leu-rich_rpt | 3.21e-03 | 271 | 99 | 6 | IPR001611 | |
| Domain | C345C | 3.59e-03 | 17 | 99 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.03e-03 | 18 | 99 | 2 | IPR008930 | |
| Domain | NTR | 4.48e-03 | 19 | 99 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.48e-03 | 19 | 99 | 2 | IPR018933 | |
| Pubmed | NCOA2 LRFN1 SYNE1 SIPA1L3 ARMCX4 CCDC177 CDC42BPB CYFIP2 MPRIP RAD50 SART1 HOOK3 CELSR2 EHMT1 SMARCA4 MACF1 NIPBL PCNT | 1.05e-09 | 963 | 108 | 18 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 ERBB2 LRFN1 RNPEPL1 TSNARE1 SIPA1L3 SFI1 CDC42BPB MPRIP C2CD2L GDPD5 CELSR2 PROM2 EHMT1 PLEC SIPA1L2 UVRAG PKN3 PCNT | 1.35e-09 | 1105 | 108 | 19 | 35748872 |
| Pubmed | SYNE1 SIPA1L3 APAF1 CDC42BPB ARHGEF15 C2CD2L EHMT1 MACF1 PCNT | 3.80e-08 | 225 | 108 | 9 | 12168954 | |
| Pubmed | ERBB2 HAUS5 ASH1L EMILIN3 C2CD2L RAD50 SART1 TFPT BRPF1 SUPT7L SMARCA2 EHMT1 SMARCA4 MACF1 CEP295 SIPA1L2 SORL1 | 6.35e-08 | 1116 | 108 | 17 | 31753913 | |
| Pubmed | NCOA2 DOCK3 FAM86B1 SYNE1 SIPA1L3 PLA2G3 CEP290 ASH1L ARMCX4 CDC42BPB MPRIP SMARCA4 MACF1 LRPAP1 PLEC UTRN NIPBL PCNT | 8.75e-08 | 1285 | 108 | 18 | 35914814 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.16e-07 | 4 | 108 | 3 | 19091768 | |
| Pubmed | SYNE1 SIPA1L3 ZNF767P CDC42BPB CYFIP2 MPRIP C2CD2L MEST TFPT GTF2H4 SUPT7L SMARCA2 EHMT1 CSTF1 GOLIM4 MACF1 UTRN NIPBL KIFC1 | 1.69e-07 | 1497 | 108 | 19 | 31527615 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.90e-07 | 5 | 108 | 3 | 17855024 | |
| Pubmed | 7.35e-07 | 234 | 108 | 8 | 36243803 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 ERBB2 TSNARE1 SIPA1L3 ASH1L CCDC85C RBBP8NL ZNF767P CDC42BPB PLEKHG4B PROM2 TBC1D22A SMARCA2 EHMT1 MACF1 HOOK2 UTRN PCNT | 7.54e-07 | 1489 | 108 | 18 | 28611215 |
| Pubmed | 8.24e-07 | 102 | 108 | 6 | 11214970 | ||
| Pubmed | DOCK3 SIPA1L3 CEP290 ZNF623 CDC42BPB ARHGEF15 DISP3 MACF1 TSPYL5 POM121B | 3.35e-06 | 493 | 108 | 10 | 15368895 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 3.44e-06 | 10 | 108 | 3 | 23129809 | |
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 15140983 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 9.55e-06 | 2 | 108 | 2 | 16565498 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 9.55e-06 | 2 | 108 | 2 | 7373044 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19062096 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8670841 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 9.55e-06 | 2 | 108 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 9.55e-06 | 2 | 108 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 9.55e-06 | 2 | 108 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 9.55e-06 | 2 | 108 | 2 | 19933335 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23163725 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 9.55e-06 | 2 | 108 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 9.55e-06 | 2 | 108 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 9.55e-06 | 2 | 108 | 2 | 15787745 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12207352 | ||
| Pubmed | LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro. | 9.55e-06 | 2 | 108 | 2 | 11557679 | |
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 9.55e-06 | 2 | 108 | 2 | 23076393 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30026462 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 9.55e-06 | 2 | 108 | 2 | 27758680 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 9.55e-06 | 2 | 108 | 2 | 34299197 | |
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 9.55e-06 | 2 | 108 | 2 | 9603422 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15576411 | ||
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 9.55e-06 | 2 | 108 | 2 | 20506482 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12480675 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 9.55e-06 | 2 | 108 | 2 | 23749435 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23918728 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23276717 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27097303 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15240517 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 9.55e-06 | 2 | 108 | 2 | 33027072 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28038711 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8940146 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 9.55e-06 | 2 | 108 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 9.55e-06 | 2 | 108 | 2 | 3037333 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23872584 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11726230 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 9.55e-06 | 2 | 108 | 2 | 1699796 | |
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 9.55e-06 | 2 | 108 | 2 | 23963727 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 9.55e-06 | 2 | 108 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 9.55e-06 | 2 | 108 | 2 | 2997024 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 9.55e-06 | 2 | 108 | 2 | 31375262 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 9.55e-06 | 2 | 108 | 2 | 23088494 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 9.55e-06 | 2 | 108 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 9.55e-06 | 2 | 108 | 2 | 8428773 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21857912 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17075831 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24638111 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 9.55e-06 | 2 | 108 | 2 | 4514997 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20333683 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 9.55e-06 | 2 | 108 | 2 | 21345967 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 34812766 | ||
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 9.55e-06 | 2 | 108 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 9.55e-06 | 2 | 108 | 2 | 3167981 | |
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 9.55e-06 | 2 | 108 | 2 | 32855269 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7545960 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 9.55e-06 | 2 | 108 | 2 | 30478150 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30041577 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2572548 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 9.55e-06 | 2 | 108 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 9.55e-06 | 2 | 108 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 9.55e-06 | 2 | 108 | 2 | 18360261 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 9.55e-06 | 2 | 108 | 2 | 18091514 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29080553 | ||
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 9.55e-06 | 2 | 108 | 2 | 22721696 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 9.55e-06 | 2 | 108 | 2 | 26814963 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 9.55e-06 | 2 | 108 | 2 | 25339671 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17728371 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18508913 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11719516 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 6149580 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 6149581 | ||
| Pubmed | Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women. | 9.55e-06 | 2 | 108 | 2 | 34418690 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12115608 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 3542363 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2387317 | ||
| Interaction | CEP63 interactions | 4.13e-06 | 179 | 104 | 8 | int:CEP63 | |
| Interaction | HOOK1 interactions | 4.27e-06 | 240 | 104 | 9 | int:HOOK1 | |
| Interaction | FAM167A interactions | 1.04e-05 | 96 | 104 | 6 | int:FAM167A | |
| Interaction | WHAMMP3 interactions | 3.54e-05 | 119 | 104 | 6 | int:WHAMMP3 | |
| Interaction | PCNT interactions | 3.57e-05 | 241 | 104 | 8 | int:PCNT | |
| Cytoband | 6p21.3 | 2.95e-05 | 250 | 108 | 6 | 6p21.3 | |
| Cytoband | 22q11.21 | 1.43e-04 | 111 | 108 | 4 | 22q11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 1.96e-04 | 503 | 108 | 7 | chr6p21 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.30e-04 | 8 | 63 | 2 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.23e-04 | 9 | 63 | 2 | 1234 | |
| GeneFamily | PDZ domain containing | 1.95e-03 | 152 | 63 | 4 | 1220 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.55e-08 | 198 | 106 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.19e-07 | 200 | 106 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 181 | 106 | 6 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 190 | 106 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.20e-06 | 199 | 106 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.20e-06 | 199 | 106 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.44e-06 | 200 | 106 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.27e-05 | 153 | 106 | 5 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.27e-05 | 153 | 106 | 5 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.59e-05 | 156 | 106 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 161 | 106 | 5 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.30e-05 | 162 | 106 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.97e-05 | 167 | 106 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.97e-05 | 167 | 106 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 6.37e-05 | 176 | 106 | 5 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 177 | 106 | 5 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.72e-05 | 178 | 106 | 5 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 7.66e-05 | 183 | 106 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 9.37e-05 | 191 | 106 | 5 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 193 | 106 | 5 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-05 | 101 | 106 | 4 | 6c4524be89cf3eb06769c2963dcded3da1e71ca0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 194 | 106 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 195 | 106 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.03e-04 | 195 | 106 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-04 | 196 | 106 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-04 | 196 | 106 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 197 | 106 | 5 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 197 | 106 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 197 | 106 | 5 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.11e-04 | 198 | 106 | 5 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.11e-04 | 198 | 106 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.11e-04 | 198 | 106 | 5 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 198 | 106 | 5 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.14e-04 | 199 | 106 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.16e-04 | 200 | 106 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.62e-07 | 199 | 105 | 9 | 1484_DN | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.13e-06 | 12 | 100 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | SIPA1L3 ASH1L CDC42BPB ARHGEF15 CYFIP2 MPRIP CELSR2 RHPN2 EXOC3L4 RP1L1 SIPA1L2 PKN3 | 6.26e-05 | 914 | 100 | 12 | EFO_0004532 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.13e-04 | 5 | 100 | 2 | C3281201 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 4.03e-04 | 9 | 100 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | immature platelet measurement | 7.32e-04 | 119 | 100 | 4 | EFO_0803541 | |
| Disease | Coffin-Siris syndrome | 8.66e-04 | 13 | 100 | 2 | C0265338 | |
| Disease | Papillary Renal Cell Carcinoma | 9.60e-04 | 128 | 100 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 9.60e-04 | 128 | 100 | 4 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 9.60e-04 | 128 | 100 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 9.60e-04 | 128 | 100 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 9.60e-04 | 128 | 100 | 4 | C1266044 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.01e-03 | 14 | 100 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 1.12e-03 | 60 | 100 | 3 | EFO_0020690 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.64e-03 | 148 | 100 | 4 | C0279702 | |
| Disease | bipolar disorder, sex interaction measurement | 1.68e-03 | 18 | 100 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.68e-03 | 18 | 100 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.68e-03 | 69 | 100 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | hydrocephalus (implicated_via_orthology) | 1.87e-03 | 19 | 100 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.87e-03 | 19 | 100 | 2 | EFO_0802076 | |
| Disease | cancer (implicated_via_orthology) | 2.22e-03 | 268 | 100 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | stroke, coronary artery disease | 2.29e-03 | 21 | 100 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.29e-03 | 21 | 100 | 2 | EFO_0022246 | |
| Disease | blood pressure | 2.51e-03 | 22 | 100 | 2 | EFO_0004325 | |
| Disease | Nasopharyngeal carcinoma | 2.51e-03 | 22 | 100 | 2 | C2931822 | |
| Disease | progranulin measurement | 2.51e-03 | 22 | 100 | 2 | EFO_0004625 | |
| Disease | clinical and behavioural ideal cardiovascular health | 2.75e-03 | 23 | 100 | 2 | EFO_0007654 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.76e-03 | 82 | 100 | 3 | EFO_0008535 | |
| Disease | breast cancer (implicated_via_orthology) | 3.24e-03 | 25 | 100 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | large artery stroke, coronary artery disease | 3.24e-03 | 25 | 100 | 2 | EFO_0001645, EFO_0005524 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DHIRRLQLINGRTGQ | 941 | O14727 | |
| ILALRRLGRQRNQHL | 666 | Q17RC7 | |
| RLGRQRNQHLLQHTQ | 671 | Q17RC7 | |
| QNLQVIRGRILHNGA | 426 | P04626 | |
| RRHNQRERLNQILLN | 2916 | Q9NR48 | |
| LQQLHLGNRSRQASR | 156 | Q9P2K9 | |
| SHALQLNNRQIRGLE | 1341 | P0C0L5 | |
| LSLQHRRAQLLDING | 416 | Q8IXS2 | |
| RGLVTRTVRQHLNLN | 396 | O95870 | |
| LEELQLGHNRIRQLA | 316 | P35858 | |
| RRHLRQNQRLLEAVG | 816 | O94989 | |
| RSQQLALLLRNATQH | 2051 | Q9HCU4 | |
| LRILRSNQHGIRRNL | 2401 | Q9HCU4 | |
| GAQLAERRLRQRLVQ | 4431 | Q96M86 | |
| INQGLDRLRRVSHQG | 231 | P30533 | |
| LRNILHQGQEAILQR | 241 | Q96C86 | |
| LNSNVQLAGLRLIRH | 2136 | Q5H9R4 | |
| AAQRNSQGAHLLQRR | 146 | Q8TE58 | |
| LLVEQGRLQLQADRH | 346 | Q92878 | |
| QLQQLLHRERDGVVR | 116 | A6NNM3 | |
| QLQQLLHRERDGVVR | 116 | A6NJZ7 | |
| RVVSRGNKLHLQLNQ | 66 | Q9Y5F0 | |
| QNRLLQDQLRVALGR | 696 | Q6WCQ1 | |
| EGRVLRRQHQRNVKL | 496 | P13196 | |
| FLARQHLLQRISIRQ | 1161 | Q9Y6X6 | |
| RHGLETQHRLNQQQL | 496 | Q96ED9 | |
| LGNLRHLILGNNQIR | 136 | Q9P244 | |
| HLILGNNQIRRVESA | 141 | Q9P244 | |
| HLRTLRRQANQANKL | 51 | Q9Y6C7 | |
| VNRRLQQHLLEIRGL | 56 | A6NKD9 | |
| ERRRLHNQLQELKGN | 296 | Q9BW19 | |
| HSRVLEQLRGNVLLN | 156 | Q8N7N1 | |
| GNRQHRRAFLISLLN | 2401 | Q6KC79 | |
| LRRGHIQRLNLRYTQ | 421 | Q8WTR4 | |
| HQRQLRRRGALPQES | 161 | Q9HB14 | |
| QLRGLVNLRHLILSN | 126 | Q9BTN0 | |
| HRQLLLRELQAKQQR | 371 | O94927 | |
| GLQSILHKNRLRNQV | 1211 | Q9Y5S2 | |
| QRHVQLLGRSIDLNR | 776 | Q96F07 | |
| GRRHLQLQTQLEQLQ | 241 | Q86VS8 | |
| LNQNAELRSRLNRIH | 431 | Q9BZF3 | |
| RRHSQALEALQQRLQ | 1811 | O95613 | |
| LTRAGLRRLQRQQQV | 241 | Q9Y5Y3 | |
| LNQHTQLEGRLQDLR | 3486 | Q9UPN3 | |
| KTLGARQRLQARRQH | 816 | A6NF01 | |
| QEALHQQRLQGHLLR | 431 | O00461 | |
| GHRVLQRLEQRRQQA | 346 | Q86WN1 | |
| HLLLAQQQLRARARA | 356 | Q8NC74 | |
| GRAQHQINGRVRQLL | 141 | Q8IYK2 | |
| QINGRVRQLLRQREV | 146 | Q8IYK2 | |
| LQEVDGQLGQQIRRH | 546 | P0C671 | |
| RRQLLSGHLTQDQVR | 126 | Q8IZD9 | |
| NRLFLRQLRASHLGN | 286 | O14523 | |
| GRNRAKHLRQTIQSL | 1256 | O15078 | |
| QLEHLQSRLRRQQQN | 501 | Q96A19 | |
| RQRLNQISHDIRQRN | 666 | O75342 | |
| RLQNIEAHLRLQTGG | 251 | Q9NS73 | |
| RHEALLQGRTRQQRQ | 511 | Q9NQR7 | |
| GSRLQAGHRQVLNLR | 641 | Q9NT22 | |
| AERRNLLSLGHNNIV | 386 | Q05048 | |
| TQALRHQRGLRLYNQ | 2546 | Q9C0D2 | |
| RSLQAQLQRLGVLHV | 406 | Q9NTJ5 | |
| RNRVVQNGLRARLQL | 1116 | Q9H9B1 | |
| LRHLGLQNRRINLLS | 131 | Q5EB52 | |
| QAQDRQLAGQLLRLR | 91 | Q9BTA0 | |
| QLAGQLLRLRAQLHR | 96 | Q9BTA0 | |
| QDRVLIRLSRLHNQQ | 121 | Q06587 | |
| SHALQLNNRQIRGLE | 1341 | P0C0L4 | |
| RLQNQRGGRIRLQDI | 131 | Q8N4E7 | |
| LRQGSAQELNLRHRG | 76 | Q6ZQY2 | |
| GHVQQLLRSSNRRLE | 51 | Q6P5Z2 | |
| RVVSRGNKLHLQLNQ | 66 | Q9UN66 | |
| LQGRLQRLLQASGNH | 76 | O43612 | |
| LQQIRRNLAHQQHGV | 401 | A8K8P3 | |
| ESQHNRQLLRGALRR | 676 | A8K8P3 | |
| QLESQLHRLRQLLEQ | 3341 | P46939 | |
| RNIAARNIVNRNGHQ | 46 | Q9P2Y5 | |
| QTQGRLHPNLRRAIQ | 656 | Q9HAU8 | |
| HLAQRLSQLLNLQLR | 476 | Q92673 | |
| NILHRLLKNGNVRNT | 46 | O14599 | |
| HRIGQQNEVRVLRLC | 1161 | P51531 | |
| HQLSLRRQQIGERLN | 7766 | Q8NF91 | |
| RALRHLRLANNQLQF | 111 | Q86X40 | |
| QLQQLLHRERDGVVR | 116 | Q9UFD9 | |
| HRIGQQNEVRVLRLC | 1191 | P51532 | |
| NNRQQLLRKRHIGND | 691 | Q9P2F8 | |
| PNNRQQLLRKRHIGN | 706 | O60292 | |
| RILRNRHDLLNVSQG | 151 | Q9BVH7 | |
| RNLEQLRLSQNHISR | 171 | P51888 | |
| GLRLLSANVRQLHQA | 31 | Q9P202 | |
| TIQLIQHNRRLRNLI | 66 | O94864 | |
| RLQQRRHQLQDKGTD | 456 | Q9NZ20 | |
| NDQQRRQLGKSHLRR | 401 | Q8IUC4 | |
| QRLLQHLQGQRKQVA | 516 | Q9NRC6 | |
| LRSSQRLQKRHQQLE | 1451 | Q9NRC6 | |
| RHRLKLANNEVGRIQ | 746 | Q9C0B6 | |
| LLRRLQTHLQSQRNC | 556 | P55201 | |
| AQRQREILNQHLRQR | 1236 | Q15596 | |
| SRGLNRVHLQCRNLQ | 6 | Q92759 | |
| LLQRRLENVENLLHN | 76 | Q75MW2 | |
| QLLLILRGQTRHQVR | 206 | Q8N966 | |
| RLHGQLQRHQQQLLA | 506 | Q9C0E2 | |
| ARQLLAGASRHQLQR | 471 | Q96NA8 | |
| NRLHQVQRITRRLQQ | 101 | P0C1Z6 | |
| TGELLLQTQQRRHRL | 1596 | Q8IWN7 | |
| LQTQQRRHRLRGLRN | 1601 | Q8IWN7 | |
| QRLQEEAQGLRNLHQ | 656 | Q8N271 | |
| LVQRIHQLQAERAQG | 41 | Q96EN9 | |
| RLVLTSNNRLQQLEH | 446 | Q96PX9 | |
| LAQRHRQQLQLELLE | 46 | I3L0S3 | |
| HRNLVDNITGQRLLE | 4436 | Q15149 | |
| GRRLRQLQQLQQLRD | 506 | O43290 | |
| VLRNHSQRQGRPTLQ | 101 | Q8WUA7 | |
| NFRQRGQLLRHQRLH | 461 | Q8N393 | |
| QLRRRALGEDLLQNH | 41 | A0A0U1RRN3 | |
| GRNHILNSDLLLLQR | 101 | O75123 | |
| VRGNQQALRAQLHQL | 111 | Q13488 | |
| GQLRLQHLERRNHLI | 231 | Q86VY4 |